Boston Scientific Corporation (BSX) - Financials, balance sheet (annual)

91.40000 EUR

1.4

1.51%

Last update May 9, 8:08 AM CEST

Market closed

Day range

91.40000

Previous close

92.80000

Open

91.40000

Access this stock data via API

Boston Scientific Corporation

91.40

1.40

1.51%

Financials

Balance sheet

Fiscal date	2024	2023	2022	2021
Total assets	39.4B	35.1B	32.5B	32.2B
Current assets	6.9B	6.5B	5.8B	6.3B
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	414M	865M	928M	1.9B
Other short term investments	—	—	—	—
Accounts receivable	2.6B	2.2B	2.0B	1.8B
Other receivables	—	—	—	—
Inventory	2.8B	2.5B	1.9B	1.6B
Prepaid assets	307M	315M	264M	205M
Restricted cash	111M	130M	149M	188M
Assets held for sale	—	—	—	0
Hedging assets	305M	159M	232M	226M
Other current assets	415M	333M	350M	385M
Non current assets	32.5B	28.6B	26.7B	25.9B
Properties	449M	439M	386M	435M
Land and improvements	144M	140M	137M	109M
Machinery furniture equipment	3.6B	3.5B	3.3B	3.3B
Construction in progress	1.0B	857M	598M	605M
Leases	—	—	—	—
Accumulated depreciation	-3.5B	-3.5B	-3.3B	-3.3B
Goodwill	40.9B	34.8B	31.7B	30.1B
Investment properties	—	—	—	—
Financial assets	79M	107M	149M	169M
Intangible assets	6.7B	6.0B	5.9B	6.1B
Investments and advances	555M	413M	407M	412M
Other non current assets	4.3B	4.4B	4.5B	4.5B
Total liabilities	17.4B	15.6B	14.9B	15.6B
Current liabilities	6.4B	4.9B	3.8B	4.3B
Accounts payable	960M	942M	862M	794M
Accrued expenses	2.6B	2.4B	1.9B	2.2B
Short term debt	1.8B	531M	20M	261M
Deferred revenue	306M	266M	220M	208M
Tax payable	268M	220M	232M	209M
Pensions	—	—	—	—
Other current liabilities	314M	328M	308M	365M
Non current liabilities	11.0B	10.7B	11.1B	11.3B
Long term provisions	149M	172M	212M	284M
Long term debt	9.4B	9.0B	9.3B	9.2B
Provision for risks and charges	357M	470M	597M	442M
Deferred liabilities	155M	134M	144M	310M
Derivative product liabilities	—	—	0	3M
Other non current liabilities	634M	625M	589M	828M
Shareholders equity
Common stock	17M	17M	17M	17M
Retained earnings	2.7B	819M	-750M	-1.4B
Other shareholders equity	275M	49M	269M	263M
Total shareholders equity	22.0B	19.5B	17.6B	16.6B
Additional paid in capital	21.1B	20.6B	20.3B	20.0B
Treasury stock	2.3B	2.3B	2.3B	2.3B
Minority interest	233M	248M	0	—